Govt, pharma industry lean on trade talks to soften Trump’s drug tariff plan
The US is India’s largest pharmaceutical export market, accounting for $9.47 billion, or 30.4%, of the country’s total pharmaceutical exports of $31.12 billion in FY26, making the proposed tariffs one of the biggest risks facing the sector.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
